Progesterone Enters Phase III

Share

The Synapse study of Progesterone has entered into Phase III trials in the United States and China. Several years ago we blogged here in NeuroNotes about the research conducted by Donald Stein, PhD and his associates at Emory University to use this commonly occurring hormone to reduce the effects of traumatic brain injury. With the move into the Phase III aspect of the study, the inclusion of progesterone in the trauma medicine arsenal is becoming more of a reality. We should start seeing interim results in 2013.

Click here to read the report in the IBIA Newsletter.

http://www.internationalbrain.org/?q=node/202

About Rolf Gainer Ph.D.

Dr. Rolf Gainer is the founder of the Neurologic Rehabilitation Institute at Brookhaven Hospital in Tulsa, Oklahoma as well as the Neurological Rehabilitation Institute of Ontario, in Toronto, Canada. Dr. Gainer is a psychologist with more than twenty-five years of experience in the treatment and rehabilitation of individuals with brain injuries and a dual diagnosis. Dr. Gainer has designed and operated innovative rehabilitation programs in the United States and Canada for individuals who have been regarded as difficult to serve. He is currently involved in conducting two outcome studies related to the long-term issues faced by individuals with brain injuries and a dual diagnosis. He has presented papers throughout the United States and Canada in many professional conferences and educational forums.
No comments yet.

Leave a Reply